Peptide-based Drug Market, Global Outlook and Forecast 2022-2028

February 2022 | 63 pages | ID: PA665FE4155BEN
Market Monitor Global

Abstracts

Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another. Peptides are distinguished from proteins on the basis of size, and as a benchmark can be understood to contain approximately 50 amino acids or less.

This report contains market size and forecasts of Peptide-based Drug in Global, including the following market information:

Global Peptide-based Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Peptide-based Drug market was valued at 33110 million in 2021 and is projected to reach US$ 59190 million by 2028, at a CAGR of 8.7% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Peptide-based Drug include Sanofi, Teva, Novo Nordisk, Takeda, Eli Lilly, AstraZeneca, Novartis, AbbVie and Ipsen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Peptide-based Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Peptide-based Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Peptide-based Drug Market Segment Percentages, by Type, 2021 (%)

• Injection
• Oral
• Other

Global Peptide-based Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Peptide-based Drug Market Segment Percentages, by Application, 2021 (%)

• Cancer
• Metabolic Disorders
• Central Nervous System
• Other

Global Peptide-based Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Peptide-based Drug Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Peptide-based Drug revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Peptide-based Drug revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Sanofi
• Teva
• Novo Nordisk
• Takeda
• Eli Lilly
• AstraZeneca
• Novartis
• AbbVie
• Ipsen
• Ferring
• Merck
• The Medicines
• J & J

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Peptide-based Drug Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Peptide-based Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL PEPTIDE-BASED DRUG OVERALL MARKET SIZE

2.1 Global Peptide-based Drug Market Size: 2021 VS 2028
2.2 Global Peptide-based Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Peptide-based Drug Players in Global Market
3.2 Top Global Peptide-based Drug Companies Ranked by Revenue
3.3 Global Peptide-based Drug Revenue by Companies
3.4 Top 3 and Top 5 Peptide-based Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Peptide-based Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Peptide-based Drug Players in Global Market
  3.6.1 List of Global Tier 1 Peptide-based Drug Companies
  3.6.2 List of Global Tier 2 and Tier 3 Peptide-based Drug Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Peptide-based Drug Market Size Markets, 2021 & 2028
  4.1.2 Injection
  4.1.3 Oral
  4.1.4 Other
4.2 By Type - Global Peptide-based Drug Revenue & Forecasts
  4.2.1 By Type - Global Peptide-based Drug Revenue, 2017-2022
  4.2.2 By Type - Global Peptide-based Drug Revenue, 2023-2028
  4.2.3 By Type - Global Peptide-based Drug Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Peptide-based Drug Market Size, 2021 & 2028
  5.1.2 Cancer
  5.1.3 Metabolic Disorders
  5.1.4 Central Nervous System
  5.1.5 Other
5.2 By Application - Global Peptide-based Drug Revenue & Forecasts
  5.2.1 By Application - Global Peptide-based Drug Revenue, 2017-2022
  5.2.2 By Application - Global Peptide-based Drug Revenue, 2023-2028
  5.2.3 By Application - Global Peptide-based Drug Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Peptide-based Drug Market Size, 2021 & 2028
6.2 By Region - Global Peptide-based Drug Revenue & Forecasts
  6.2.1 By Region - Global Peptide-based Drug Revenue, 2017-2022
  6.2.2 By Region - Global Peptide-based Drug Revenue, 2023-2028
  6.2.3 By Region - Global Peptide-based Drug Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Peptide-based Drug Revenue, 2017-2028
  6.3.2 US Peptide-based Drug Market Size, 2017-2028
  6.3.3 Canada Peptide-based Drug Market Size, 2017-2028
  6.3.4 Mexico Peptide-based Drug Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Peptide-based Drug Revenue, 2017-2028
  6.4.2 Germany Peptide-based Drug Market Size, 2017-2028
  6.4.3 France Peptide-based Drug Market Size, 2017-2028
  6.4.4 U.K. Peptide-based Drug Market Size, 2017-2028
  6.4.5 Italy Peptide-based Drug Market Size, 2017-2028
  6.4.6 Russia Peptide-based Drug Market Size, 2017-2028
  6.4.7 Nordic Countries Peptide-based Drug Market Size, 2017-2028
  6.4.8 Benelux Peptide-based Drug Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Peptide-based Drug Revenue, 2017-2028
  6.5.2 China Peptide-based Drug Market Size, 2017-2028
  6.5.3 Japan Peptide-based Drug Market Size, 2017-2028
  6.5.4 South Korea Peptide-based Drug Market Size, 2017-2028
  6.5.5 Southeast Asia Peptide-based Drug Market Size, 2017-2028
  6.5.6 India Peptide-based Drug Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Peptide-based Drug Revenue, 2017-2028
  6.6.2 Brazil Peptide-based Drug Market Size, 2017-2028
  6.6.3 Argentina Peptide-based Drug Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Peptide-based Drug Revenue, 2017-2028
  6.7.2 Turkey Peptide-based Drug Market Size, 2017-2028
  6.7.3 Israel Peptide-based Drug Market Size, 2017-2028
  6.7.4 Saudi Arabia Peptide-based Drug Market Size, 2017-2028
  6.7.5 UAE Peptide-based Drug Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Sanofi
  7.1.1 Sanofi Corporate Summary
  7.1.2 Sanofi Business Overview
  7.1.3 Sanofi Peptide-based Drug Major Product Offerings
  7.1.4 Sanofi Peptide-based Drug Revenue in Global Market (2017-2022)
  7.1.5 Sanofi Key News
7.2 Teva
  7.2.1 Teva Corporate Summary
  7.2.2 Teva Business Overview
  7.2.3 Teva Peptide-based Drug Major Product Offerings
  7.2.4 Teva Peptide-based Drug Revenue in Global Market (2017-2022)
  7.2.5 Teva Key News
7.3 Novo Nordisk
  7.3.1 Novo Nordisk Corporate Summary
  7.3.2 Novo Nordisk Business Overview
  7.3.3 Novo Nordisk Peptide-based Drug Major Product Offerings
  7.3.4 Novo Nordisk Peptide-based Drug Revenue in Global Market (2017-2022)
  7.3.5 Novo Nordisk Key News
7.4 Takeda
  7.4.1 Takeda Corporate Summary
  7.4.2 Takeda Business Overview
  7.4.3 Takeda Peptide-based Drug Major Product Offerings
  7.4.4 Takeda Peptide-based Drug Revenue in Global Market (2017-2022)
  7.4.5 Takeda Key News
7.5 Eli Lilly
  7.5.1 Eli Lilly Corporate Summary
  7.5.2 Eli Lilly Business Overview
  7.5.3 Eli Lilly Peptide-based Drug Major Product Offerings
  7.5.4 Eli Lilly Peptide-based Drug Revenue in Global Market (2017-2022)
  7.5.5 Eli Lilly Key News
7.6 AstraZeneca
  7.6.1 AstraZeneca Corporate Summary
  7.6.2 AstraZeneca Business Overview
  7.6.3 AstraZeneca Peptide-based Drug Major Product Offerings
  7.6.4 AstraZeneca Peptide-based Drug Revenue in Global Market (2017-2022)
  7.6.5 AstraZeneca Key News
7.7 Novartis
  7.7.1 Novartis Corporate Summary
  7.7.2 Novartis Business Overview
  7.7.3 Novartis Peptide-based Drug Major Product Offerings
  7.7.4 Novartis Peptide-based Drug Revenue in Global Market (2017-2022)
  7.7.5 Novartis Key News
7.8 AbbVie
  7.8.1 AbbVie Corporate Summary
  7.8.2 AbbVie Business Overview
  7.8.3 AbbVie Peptide-based Drug Major Product Offerings
  7.8.4 AbbVie Peptide-based Drug Revenue in Global Market (2017-2022)
  7.8.5 AbbVie Key News
7.9 Ipsen
  7.9.1 Ipsen Corporate Summary
  7.9.2 Ipsen Business Overview
  7.9.3 Ipsen Peptide-based Drug Major Product Offerings
  7.9.4 Ipsen Peptide-based Drug Revenue in Global Market (2017-2022)
  7.9.5 Ipsen Key News
7.10 Ferring
  7.10.1 Ferring Corporate Summary
  7.10.2 Ferring Business Overview
  7.10.3 Ferring Peptide-based Drug Major Product Offerings
  7.10.4 Ferring Peptide-based Drug Revenue in Global Market (2017-2022)
  7.10.5 Ferring Key News
7.11 Merck
  7.11.1 Merck Corporate Summary
  7.11.2 Merck Business Overview
  7.11.3 Merck Peptide-based Drug Major Product Offerings
  7.11.4 Merck Peptide-based Drug Revenue in Global Market (2017-2022)
  7.11.5 Merck Key News
7.12 The Medicines
  7.12.1 The Medicines Corporate Summary
  7.12.2 The Medicines Business Overview
  7.12.3 The Medicines Peptide-based Drug Major Product Offerings
  7.12.4 The Medicines Peptide-based Drug Revenue in Global Market (2017-2022)
  7.12.5 The Medicines Key News
7.13 J & J
  7.13.1 J & J Corporate Summary
  7.13.2 J & J Business Overview
  7.13.3 J & J Peptide-based Drug Major Product Offerings
  7.13.4 J & J Peptide-based Drug Revenue in Global Market (2017-2022)
  7.13.5 J & J Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Peptide-based Drug Market Opportunities & Trends in Global Market
Table 2. Peptide-based Drug Market Drivers in Global Market
Table 3. Peptide-based Drug Market Restraints in Global Market
Table 4. Key Players of Peptide-based Drug in Global Market
Table 5. Top Peptide-based Drug Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Peptide-based Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Peptide-based Drug Revenue Share by Companies, 2017-2022
Table 8. Global Companies Peptide-based Drug Product Type
Table 9. List of Global Tier 1 Peptide-based Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Peptide-based Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Peptide-based Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Peptide-based Drug Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Peptide-based Drug Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Peptide-based Drug Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Peptide-based Drug Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Peptide-based Drug Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Peptide-based Drug Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Peptide-based Drug Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Peptide-based Drug Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Peptide-based Drug Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Peptide-based Drug Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Peptide-based Drug Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Peptide-based Drug Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Peptide-based Drug Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Peptide-based Drug Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Peptide-based Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Peptide-based Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Peptide-based Drug Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Peptide-based Drug Revenue, (US$, Mn), 2023-2028
Table 30. Sanofi Corporate Summary
Table 31. Sanofi Peptide-based Drug Product Offerings
Table 32. Sanofi Peptide-based Drug Revenue (US$, Mn), (2017-2022)
Table 33. Teva Corporate Summary
Table 34. Teva Peptide-based Drug Product Offerings
Table 35. Teva Peptide-based Drug Revenue (US$, Mn), (2017-2022)
Table 36. Novo Nordisk Corporate Summary
Table 37. Novo Nordisk Peptide-based Drug Product Offerings
Table 38. Novo Nordisk Peptide-based Drug Revenue (US$, Mn), (2017-2022)
Table 39. Takeda Corporate Summary
Table 40. Takeda Peptide-based Drug Product Offerings
Table 41. Takeda Peptide-based Drug Revenue (US$, Mn), (2017-2022)
Table 42. Eli Lilly Corporate Summary
Table 43. Eli Lilly Peptide-based Drug Product Offerings
Table 44. Eli Lilly Peptide-based Drug Revenue (US$, Mn), (2017-2022)
Table 45. AstraZeneca Corporate Summary
Table 46. AstraZeneca Peptide-based Drug Product Offerings
Table 47. AstraZeneca Peptide-based Drug Revenue (US$, Mn), (2017-2022)
Table 48. Novartis Corporate Summary
Table 49. Novartis Peptide-based Drug Product Offerings
Table 50. Novartis Peptide-based Drug Revenue (US$, Mn), (2017-2022)
Table 51. AbbVie Corporate Summary
Table 52. AbbVie Peptide-based Drug Product Offerings
Table 53. AbbVie Peptide-based Drug Revenue (US$, Mn), (2017-2022)
Table 54. Ipsen Corporate Summary
Table 55. Ipsen Peptide-based Drug Product Offerings
Table 56. Ipsen Peptide-based Drug Revenue (US$, Mn), (2017-2022)
Table 57. Ferring Corporate Summary
Table 58. Ferring Peptide-based Drug Product Offerings
Table 59. Ferring Peptide-based Drug Revenue (US$, Mn), (2017-2022)
Table 60. Merck Corporate Summary
Table 61. Merck Peptide-based Drug Product Offerings
Table 62. Merck Peptide-based Drug Revenue (US$, Mn), (2017-2022)
Table 63. The Medicines Corporate Summary
Table 64. The Medicines Peptide-based Drug Product Offerings
Table 65. The Medicines Peptide-based Drug Revenue (US$, Mn), (2017-2022)
Table 66. J & J Corporate Summary
Table 67. J & J Peptide-based Drug Product Offerings
Table 68. J & J Peptide-based Drug Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Peptide-based Drug Segment by Type in 2021
Figure 2. Peptide-based Drug Segment by Application in 2021
Figure 3. Global Peptide-based Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Peptide-based Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Peptide-based Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Peptide-based Drug Revenue in 2021
Figure 8. By Type - Global Peptide-based Drug Revenue Market Share, 2017-2028
Figure 9. By Application - Global Peptide-based Drug Revenue Market Share, 2017-2028
Figure 10. By Region - Global Peptide-based Drug Revenue Market Share, 2017-2028
Figure 11. By Country - North America Peptide-based Drug Revenue Market Share, 2017-2028
Figure 12. US Peptide-based Drug Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Peptide-based Drug Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Peptide-based Drug Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Peptide-based Drug Revenue Market Share, 2017-2028
Figure 16. Germany Peptide-based Drug Revenue, (US$, Mn), 2017-2028
Figure 17. France Peptide-based Drug Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Peptide-based Drug Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Peptide-based Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Peptide-based Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Peptide-based Drug Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Peptide-based Drug Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Peptide-based Drug Revenue Market Share, 2017-2028
Figure 24. China Peptide-based Drug Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Peptide-based Drug Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Peptide-based Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Peptide-based Drug Revenue, (US$, Mn), 2017-2028
Figure 28. India Peptide-based Drug Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Peptide-based Drug Revenue Market Share, 2017-2028
Figure 30. Brazil Peptide-based Drug Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Peptide-based Drug Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Peptide-based Drug Revenue Market Share, 2017-2028
Figure 33. Turkey Peptide-based Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Peptide-based Drug Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Peptide-based Drug Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Peptide-based Drug Revenue, (US$, Mn), 2017-2028
Figure 37. Sanofi Peptide-based Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Teva Peptide-based Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novo Nordisk Peptide-based Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Takeda Peptide-based Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Eli Lilly Peptide-based Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. AstraZeneca Peptide-based Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Novartis Peptide-based Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. AbbVie Peptide-based Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Ipsen Peptide-based Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Ferring Peptide-based Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Merck Peptide-based Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. The Medicines Peptide-based Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. J & J Peptide-based Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)